A new study has discovered that drugs for diabetes and weight loss could significantly reduce mortality for Americans. Researchers at Swiss Re, a reinsurance company in Zurich, Switzerland, released ...

The continued use of GLP-1 weight loss drugs could cut mortality rates by up to 6.4% by 2045, according to new research spearheaded by Swiss Re. Titled "The future of metabolic health and weight loss ...

WASHINGTON — More than 1 in 4 U.S. adults with diabetes used one of the injectable medicines that target the GLP-1 protein last year, the Centers for Disease Control and Prevention said on Thursday.

FRANKFURT, Sept 17 (Reuters) - Reinsurance company Swiss Re (SRENH.S), opens new tab said on Wednesday that widespread use of GLP-1 drugs to treat obesity could reduce the annual rate of death by up ...